Background: Prior studies of cardiac rhythm management devices (pacemakers [PM] and implantable cardioverter defibrillators [ICD]) utilization in the United States have been limited to the ...

研究人员为评估 rTOF 高风险患者 TMM+ICD 与 TMM 预防 SCD 的成本效益，建模研究，发现 TMM+ICD 具成本效益。 植入式心律转复除颤器（Implantable cardioverter-defibrillators，ICDs）越来越多地应用于先天性心脏病患者，最常见于手术修复后的法洛四联症 ...

Background Cardiac surgery carries a heightened risk of bradyarrhythmias, but current permanent pacemaker (PPM) implantation ...

We report the case of a 51-year-old female who underwent placement of an implantable cardiac defibrillator (ICD) and a biventricular pacemaker and who immediately postoperatively experienced ...

Multiple implantable cardioverter-defibrillator (ICD) shocks can impair a patient's quality of life, and the long-term prognosis associated with shocks remains undefined. In 2008, two published ...

An automated implantable cardioverter defibrillator (ICD or AICD) is a permanent device in which a lead (wire) inserts into the right ventricle and monitors the heart rhythm. It is implanted ...

AtaCor Medical launched its clinical study evaluating its extravascular implantable cardioverter defibrillator (EV-ICD) lead ...

AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management, announced ...

Better imaging parameters may exist for risk stratification in nonischemic dilated cardiomyopathy (NIDCM), based on a ...